Singh Shawn - Insider Non-Derivative Transactions at VistaGen Therapeutics, Inc. (VTGN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 28, 2024, Singh Shawn's relationship to VistaGen Therapeutics, Inc. (VTGN) is Director,Officer (CHIEF EXECUTIVE OFFICER), and currently has 10,487 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VTGN insiders.
Data Source: SEC.
Singh Shawn - Insider Non-Derivative Transactions of VTGN Common Stock
Singh Shawn - Insider Non-Derivative Transactions at VTGN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 29, 2024 | Acquisition -- (Common Stock) | 4854 | 2.96 | 10487 |
| Dec 30, 2023 | Acquisition -- (Common Stock) | 167 | 1.72 | 5633 |
| Jul 1, 2023 | Acquisition -- (Common Stock) | 167 | 1.59 | 5466 |
| Dec 31, 2022 | Acquisition -- (Common Stock) | 5000 | 0.09 | 158998 |